SK bioscience and Hilleman to co-develop novel vaccine platforms

To progress on end-to-end vaccine research and early-stage development including vaccine platform development South Korea's SK bioscience has entered a strategic partnership with Singapore based Hilleman Laboratories to co-develop new vaccine …